USPH
U S PHYSICAL THERAPY INC /NV
$65.56
-0.35%
$997.7M
No data for this timeframe.
Vol
Market Cap$997.7M
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (85%)
Inst. Holders50 funds
Inst. Value$803.9M
Inst. Activity3 buys / 4 sells
Insider Activity2B / 4S
Insider Net $-$397.1K
SEC Reports3
Recent Activity
Jun 9, 2026
Insider
Minan Peter Francis bought 288 shares
Director @ $61.50 ($17.7K)
Jun 8, 2026
Insider
Minan Peter Francis bought 492 shares
Director @ $63.14 ($31.1K)
May 19, 2026
Insider
Gilmartin Kathleen A was granted 2,306 shares
Director @ $61.61 ($142.1K)
May 6, 2026
SEC
USPH reported Q1 2026 revenue of $198.3M (+7.9% YoY), but GAAP net income fell to $5.0M from $9.9M and GAAP EPS was a lo
8-K — Impact 6/10
May 6, 2026
earnings_calendar
USPH Q1 2026 Earnings Scheduled — 2026-05-06
Apr 15, 2026
SEC
U.S. Physical Therapy, Inc. (USPH) entered into a $450 million credit facility, consisting of a $175 million term loan a
8-K — Impact 7/10
Feb 26, 2026
SEC
U.S. Physical Therapy reported strong 2025 financial results with 16.2% growth in Adjusted EBITDA to $95.0 million and a
8-K — Impact 8/10
Inst.
SCHRODER INVESTMENT MANAGEMENT GROUP — TRIM
256,515 shares ($19.2M)
Price Targets
$93.67
+42.9% upside
Strong Buy
Current $65.56
Low $88.00
Median $93.00
High $100.00
6 analysts
$88.00
$100.00
Analyst Ratings
5Strong Buy
6Buy
2Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 13, 2026 | Barrington Research | MAINTAIN | Outperform → Outperform |
| May 8, 2026 | Citizens | MAINTAIN | Market Outperform → Market Outperform |
| Feb 20, 2026 | Barrington Research | MAINTAIN | Outperform → Outperform |
| Jan 5, 2026 | Barrington Research | MAINTAIN | Outperform → Outperform |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.82 ▲ +1.4% | $0.64 — $0.94 | 1% YoY | 6 |
| Next Q | $0.78 ▲ +4.5% | $0.70 — $0.87 | 19% YoY | 6 |
| Current FY | $2.81 ▼ -2.4% | $2.10 — $3.17 | 7% YoY | 7 |
| Next FY | $3.41 ▲ +3.0% | $3.19 — $3.81 | 22% YoY | 7 |
Latest Reports
BEARISH
8-K
6/10
USPH reported Q1 2026 revenue of $198.3M (+7.9% YoY), but GAAP net income fell to $5.0M from $9.9M and GAAP EPS was a lo
May 6, 2026
BULLISH
8-K
7/10
U.S. Physical Therapy, Inc. (USPH) entered into a $450 million credit facility, consisting of a $175 million term loan a
Apr 15, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $165.5M | — |
| KAYNE ANDERSON RUDNICK INVESTMENT | $79.9M | — |
| MORGAN STANLEY | $75.1M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $49.8M | — |
| STATE STREET CORP | $48.9M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 9, 2026 | Minan Peter | BUY | $17.7K |
| Jun 8, 2026 | Minan Peter | BUY | $31.1K |
| May 19, 2026 | Gilmartin Kathleen | A | $142.1K |
| May 19, 2026 | Harris Bernard | A | $142.1K |
| May 19, 2026 | Minan Peter | A | $142.1K |
50 institutional holders with $803.9M total value (10,719,054 shares) as of 2026-Q1. Top holders: BlackRock,, KAYNE, MORGAN. Net selling activity: 4 institutions trimmed/exited vs 3 added.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 2,208,511 | $165.5M | 20.6% | — |
| 2 | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,065,856 | $79.9M | 9.9% | — |
| 3 | MORGAN STANLEY | 1,002,468 | $75.1M | 9.3% | — |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 664,062 | $49.8M | 6.2% | — |
| 5 | STATE STREET CORP | 648,387 | $48.9M | 6.1% | — |
| 6 | BANK OF AMERICA CORP /DE/ | 554,621 | $41.6M | 5.2% | ADD +57.6% |
| 7 | DIMENSIONAL FUND ADVISORS LP | 507,394 | $38.0M | 4.7% | — |
| 8 | Boston Trust Walden Corp | 400,109 | $30.0M | 3.7% | — |
| 9 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 377,863 | $28.3M | 3.5% | NEW |
| 10 | VANGUARD PORTFOLIO MANAGEMENT LLC | 312,309 | $23.4M | 2.9% | — |
| 11 | ENVESTNET ASSET MANAGEMENT INC | 273,109 | $20.5M | 2.5% | — |
| 12 | SCHRODER INVESTMENT MANAGEMENT GROUP | 256,515 | $19.2M | 2.4% | TRIM -29.6% |
| 13 | Point72 Asset Management, L.P. | 241,402 | $18.1M | 2.3% | TRIM -37.3% |
| 14 | FMR LLC | 148,034 | $11.1M | 1.4% | — |
| 15 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 146,968 | $11.0M | 1.4% | — |
| 16 | Rockefeller Capital Management L.P. | 134,140 | $10.1M | 1.3% | TRIM -47.6% |
| 17 | ROYAL BANK OF CANADA | 133,777 | $10.0M | 1.2% | — |
| 18 | WELLS FARGO & COMPANY/MN | 126,168 | $9.5M | 1.2% | — |
| 19 | SEI INVESTMENTS CO | 118,323 | $8.9M | 1.1% | — |
| 20 | WELLINGTON MANAGEMENT GROUP LLP | 114,877 | $8.6M | 1.1% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | TRIM | 364,253 | 256,515 | -29.6% | $19.2M | 2026-Q1 |
| Point72 Asset Management, L.P. | TRIM | 385,189 | 241,402 | -37.3% | $18.1M | 2026-Q1 |
| MARSHALL WACE, LLP | DOUBLED | 7,718 | 25,563 | +231.2% | $1.9M | 2026-Q1 |
| BALYASNY ASSET MANAGEMENT L.P. | ADD | 10,037 | 19,376 | +93.0% | $1.5M | 2026-Q1 |
| FIFTH THIRD BANCORP | DOUBLED | 390 | 10,298 | +2540.5% | $771.9K | 2026-Q1 |
| M&T BANK CORP | NEAR_EXIT | 28,676 | 3,977 | -86.1% | $298.1K | 2026-Q1 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | TRIM | 4,052 | 2,809 | -30.7% | $207.1K | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | ADD | 317,200 | 499,965 | +57.6% | $39.0M | 2025-Q4 |
| Point72 Asset Management, L.P. | DOUBLED | 123,026 | 385,189 | +213.1% | $30.1M | 2025-Q4 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | ADD | 249,635 | 364,253 | +45.9% | $29.6M | 2025-Q4 |
| Rockefeller Capital Management L.P. | TRIM | 340,812 | 178,690 | -47.6% | $14.0M | 2025-Q4 |
| FIRST TRUST ADVISORS LP | DOUBLED | 9,875 | 69,834 | +607.2% | $5.5M | 2025-Q4 |
| VICTORY CAPITAL MANAGEMENT INC | DOUBLED | 33,286 | 66,888 | +100.9% | $5.2M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 104,845 | 62,374 | -40.5% | $4.9M | 2025-Q4 |
| BROWN BROTHERS HARRIMAN & CO | DOUBLED | 9,950 | 28,245 | +183.9% | $2.2M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 60,267 | 25,026 | -58.5% | $2.0M | 2025-Q4 |
| M&T BANK CORP | DOUBLED | 10,517 | 28,676 | +172.7% | $1.9M | 2025-Q4 |
| Neuberger Berman Group LLC | TRIM | 19,260 | 9,868 | -48.8% | $770.6K | 2025-Q4 |
| MARSHALL WACE, LLP | NEAR_EXIT | 44,816 | 7,718 | -82.8% | $602.7K | 2025-Q4 |
| D. E. Shaw & Co., Inc. | NEAR_EXIT | 44,586 | 3,392 | -92.4% | $264.9K | 2025-Q4 |
| State of Tennessee, Department of Treasury | TRIM | 5,861 | 2,973 | -49.3% | $249.3K | 2025-Q4 |
| FIFTH THIRD BANCORP | TRIM | 702 | 390 | -44.4% | $30.5K | 2025-Q4 |
| Allworth Financial LP | ADD | 18 | 29 | +61.1% | $2.3K | 2025-Q4 |
| CWM, LLC | TRIM | 968 | 589 | -39.2% | $46.00 | 2025-Q4 |
| BNP Paribas Asset Management Holding S.A. | ADD | 62 | 110 | +77.4% | $9.00 | 2025-Q4 |
10 unique insiders with 22 transactions. Net insider value: -$397.1K ($48.8K bought, $445.8K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | Minan Peter Francis | Director | BUY | 288 | $61.50 | $17.7K |
| Jun 8, 2026 | Minan Peter Francis | Director | BUY | 492 | $63.14 | $31.1K |
| May 19, 2026 | Gilmartin Kathleen A | Director | AWARD | 2,306 | $61.61 | $142.1K |
| May 19, 2026 | Harris Bernard A Jr | Director | AWARD | 2,306 | $61.61 | $142.1K |
| May 19, 2026 | Minan Peter Francis | Director | AWARD | 2,306 | $61.61 | $142.1K |
| May 19, 2026 | Swanson Regg E. | Director | AWARD | 2,306 | $61.61 | $142.1K |
| May 19, 2026 | Motsenbocker Anne | Director | AWARD | 2,306 | $61.61 | $142.1K |
| May 19, 2026 | Gilmartin Kathleen A | Director | AWARD | 2,306 | — | — |
| May 19, 2026 | Harris Bernard A Jr | Director | AWARD | 2,306 | — | — |
| May 19, 2026 | Minan Peter Francis | Director | AWARD | 2,306 | — | — |
| May 19, 2026 | Motsenbocker Anne | Director | AWARD | 2,306 | — | — |
| May 19, 2026 | Swanson Regg E. | Director | AWARD | 2,306 | — | — |
| Mar 11, 2026 | REEVE GRAHAM D. | COO | SELL | 662 | $78.86 | $52.2K |
| Mar 9, 2026 | HENDRICKSON CAREY P | Chief Financial Officer | D | 10,000 | — | — |
| Mar 9, 2026 | REEVE GRAHAM D. | COO | SELL | 1 | $78.52 | $78.52 |
| Mar 6, 2026 | REEVE GRAHAM D. | COO | SELL | 1,807 | $82.25 | $148.6K |
| Mar 6, 2026 | Binstein Richard | EVP Gen'l Counsel & Secretary | SELL | 3,000 | $81.64 | $244.9K |
| Feb 23, 2026 | READING CHRISTOPHER J | Chairman of the Board and CEO | AWARD | 25,000 | — | — |
| Feb 23, 2026 | Binstein Richard | EVP Gen'l Counsel & Secretary | AWARD | 10,000 | — | — |
| Feb 23, 2026 | HENDRICKSON CAREY P | Chief Financial Officer | AWARD | 10,000 | — | — |
| Feb 23, 2026 | Williams Eric Joseph | President and COO | AWARD | 15,000 | — | — |
| Feb 23, 2026 | REEVE GRAHAM D. | COO | AWARD | 10,000 | — | — |
3 SEC filing reports analyzed. Sentiment: 2 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 7.0/10.
BEARISH
8-K
6/10
USPH reported Q1 2026 revenue of $198.3M (+7.9% YoY), but GAAP net income fell to $5.0M from $9.9M a
May 6, 2026
BULLISH
8-K
7/10
U.S. Physical Therapy, Inc. (USPH) entered into a $450 million credit facility, consisting of a $175
Apr 15, 2026
BULLISH
8-K
8/10
U.S. Physical Therapy reported strong 2025 financial results with 16.2% growth in Adjusted EBITDA to
Feb 26, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (85% buy). Based on 13 analysts: 5 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$93.67 mean target
+42.9% upside
Strong Buy (3.00)
$88.00 Low
$100.00 High
| Metric | Value |
|---|---|
| Current Price | $65.56 |
| Target Low | $88.00 |
| Target Mean | $93.67 |
| Target Median | $93.00 |
| Target High | $100.00 |
| # Analysts | 6 |
| Recommendation | Strong Buy (3.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.82 | $0.64 | $0.94 | 0.7% | +1.4% | 2↑ 3↓ | $0.2B | 7.1% | 6 |
| Next Q 2026-09-30 |
$0.78 | $0.70 | $0.87 | 18.8% | +4.5% | 1↑ 3↓ | $0.2B | 7.4% | 6 |
| Current FY 2026-12-31 |
$2.81 | $2.10 | $3.17 | 6.7% | -2.4% | 1↑ 6↓ | $0.8B | 7.4% | 7 |
| Next FY 2027-12-31 |
$3.41 | $3.19 | $3.81 | 21.6% | +3.0% | 3↑ 4↓ | $0.9B | 6.8% | 7 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.816 | |
| 7d ago | $0.814 | +0.002 |
| 30d ago | $0.804 | +0.011 |
| 60d ago | $0.804 | +0.011 |
| 90d ago | $0.897 | -0.081 |
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 13, 2026 | Barrington Research | MAINTAIN | Outperform | Outperform |
| May 8, 2026 | Citizens | MAINTAIN | Market Outperform | Market Outperform |
| Feb 20, 2026 | Barrington Research | MAINTAIN | Outperform | Outperform |
| Jan 5, 2026 | Barrington Research | MAINTAIN | Outperform | Outperform |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 5 | 6 | 2 | 0 | 0 | 85% | |
| May 1, 2026 | 5 | 6 | 2 | 0 | 0 | 85% | |
| Apr 1, 2026 | 5 | 6 | 2 | 0 | 0 | 85% | |
| Mar 1, 2026 | 5 | 6 | 2 | 0 | 0 | 85% | |
| Feb 1, 2026 | 5 | 6 | 2 | 0 | 0 | 85% | |
| Jan 1, 2026 | 5 | 6 | 2 | 0 | 0 | 85% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 6, 2026
earnings_calendar
USPH Q1 2026 Earnings Scheduled — 2026-05-06
Apr 30, 2026
earnings_calendar
USPH Q1 2026 Earnings Scheduled — 2026-04-30
Mar 12, 2026
short_interest
FTD: USPH — 124,971 shares ($10.0M) failed to deliver
Settlement: 20260312, Price: $79.84, FTD Value: $9,977,684.64, U.S.PHYSICAL THERAPY INC
Feb 25, 2026
earnings_calendar
USPH Q4 2025 Earnings After Market Close — 2026-02-25